Literature DB >> 4940008

Hydroxyurea and radiotherapy in head and neck cancer. Results of a prospective controlled study in 126 patients.

S Stefani, R W Eells, J Abbate.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4940008     DOI: 10.1148/101.2.391

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  9 in total

1.  A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma.

Authors:  J V Salvajoli; H Morioka; N Trippe; L P Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin.

Authors:  S Choi; M Kobayashi; J Wang; H Habelhah; F Okada; J Hamada; T Moriuchi; Y Totsuka; M Hosokawa
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Update in cancer chemotherapy: head and neck cancer, Part 2.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-11       Impact factor: 1.798

Review 4.  Can cancer chemotherapy enhance the malignant behaviour of tumours?

Authors:  T J McMillan; I R Hart
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 5.  Oral chemotherapy in head and neck cancer.

Authors:  B E Brockstein; E E Vokes
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 6.  Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.

Authors:  Ambika Parmar; Michaelina Macluskey; Niall Mc Goldrick; David I Conway; Anne-Marie Glenny; Janet E Clarkson; Helen V Worthington; Kelvin Kw Chan
Journal:  Cochrane Database Syst Rev       Date:  2021-12-20

7.  A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neck.

Authors:  J J Beitler; R V Smith; H Haynes; C E Silver; A Quish; T Kotz; M Serrano; A Brook; S Wadler
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

8.  Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression.

Authors:  Roman A Blaheta; Frederick H Daher; Martin Michaelis; Christoph Hasenberg; Eva M Weich; Dietger Jonas; Rouslan Kotchetkov; Hans Willhelm Doerr; Jindrich Cinatl
Journal:  BMC Cancer       Date:  2006-12-21       Impact factor: 4.430

9.  Adjuvant chemotherapy in head and neck cancer.

Authors:  P M Stell; N S Rawson
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.